139 related articles for article (PubMed ID: 32754549)
1. Down syndrome presenting with different hematological manifestations: A case series of four cases.
Shangpliang D; Dey B; Das J; Baishya P; Raphael V; Khonglah Y
J Family Med Prim Care; 2020 May; 9(5):2569-2572. PubMed ID: 32754549
[TBL] [Abstract][Full Text] [Related]
2. Down syndrome with different hematological manifestations: a short series of 3 cases with review of literature.
Manivannan P; Prasaad PR; Kar R; Basu D
Indian J Hematol Blood Transfus; 2013 Mar; 29(1):31-4. PubMed ID: 24426330
[TBL] [Abstract][Full Text] [Related]
3. Hematological disorders in children with Down syndrome.
Triarico S; Trombatore G; Capozza MA; Romano A; Mastrangelo S; Attinà G; Maurizi P; Ruggiero A
Expert Rev Hematol; 2022 Feb; 15(2):127-135. PubMed ID: 35184659
[TBL] [Abstract][Full Text] [Related]
4. Distinctive hematological abnormalities in East Asian neonates and children with Down syndrome.
Kim DW; Kim HR; Shin MG; Baek HJ; Kook H; Hwang TJ; Shin JH; Suh SP; Ryang DW
Int J Lab Hematol; 2011 Aug; 33(4):369-77. PubMed ID: 21692995
[TBL] [Abstract][Full Text] [Related]
5. PRAME immunohistochemical staining in transient abnormal myelopoiesis and myeloid leukemia associated with Down syndrome.
Chisholm KM; Rivetta CV; Heerema-McKenney A
Ann Clin Lab Sci; 2015; 45(2):121-7. PubMed ID: 25887863
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
Watanabe K
Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
[TBL] [Abstract][Full Text] [Related]
8. Optimizing therapy for myeloid disorders of Down syndrome.
Webb DK
Br J Haematol; 2005 Oct; 131(1):3-7. PubMed ID: 16173956
[TBL] [Abstract][Full Text] [Related]
9. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
10. Myeloid Leukemia of Down Syndrome.
Kosmidou A; Tragiannidis A; Gavriilaki E
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444375
[TBL] [Abstract][Full Text] [Related]
11. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
Roy A; Roberts I; Vyas P
Semin Fetal Neonatal Med; 2012 Aug; 17(4):196-201. PubMed ID: 22421527
[TBL] [Abstract][Full Text] [Related]
12. GATA1 mutations in acute leukemia in children with Down syndrome.
Magalhães IQ; Splendore A; Emerenciano M; Figueiredo A; Ferrari I; Pombo-de-Oliveira MS
Cancer Genet Cytogenet; 2006 Apr; 166(2):112-6. PubMed ID: 16631466
[TBL] [Abstract][Full Text] [Related]
13. Clonal Myeloproliferative Disorders in Patients with Down Syndrome-Treatment and Outcome Results from an Institution in Argentina.
Pennella CL; Cassina TM; Rossi JG; Baialardo EM; Rubio P; Deu MA; Peruzzo L; Guitter MR; Sanchez de La Rosa CG; Alfaro EM; Felice MS
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805057
[TBL] [Abstract][Full Text] [Related]
14. Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions.
van den Akker TA; Liu YC; Liu H; Chapman J; Levine JM; Weinberg OK; Geyer JT
Pathobiology; 2024; 91(1):89-98. PubMed ID: 36996802
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome.
Grimm J; Heckl D; Klusmann JH
Front Oncol; 2021; 11():636633. PubMed ID: 33777792
[TBL] [Abstract][Full Text] [Related]
16. [Myeloid proliferations related to Down syndrome].
Hasegawa D
Rinsho Ketsueki; 2019; 60(9):1299-1307. PubMed ID: 31597856
[TBL] [Abstract][Full Text] [Related]
17. Down's Syndrome-Transient Abnormal Myelopoiesis and Acute Leukaemia.
Bain B
Leuk Lymphoma; 1991; 3(5-6):309-17. PubMed ID: 27467421
[TBL] [Abstract][Full Text] [Related]
18. Evolution of myeloid leukemia in children with Down syndrome.
Saida S
Int J Hematol; 2016 Apr; 103(4):365-72. PubMed ID: 26910243
[TBL] [Abstract][Full Text] [Related]
19. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study.
Brouwer N; Matarraz S; Nierkens S; Hofmans M; Nováková M; da Costa ES; Fernandez P; Bras AE; de Mello FV; Mejstrikova E; Philippé J; Grigore GE; Pedreira CE; van Dongen JJM; Orfao A; van der Velden VHJ; On Behalf Of The EuroFlow Consortium
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]